Combination GnRH antagonists for endometriosis: Balancing efficacy with side effects.

Cell Rep Med

MRC Centre for Reproductive Health, University of Edinburgh, Edinburgh EH16 4TJ, Scotland, UK. Electronic address:

Published: September 2022

Endometriosis is a chronic pain condition affecting 1 in 10 women. There is an unmet need for better medical treatments for endometriosis. We spotlight trials of a single preparation combined HRT-GnRH antagonist (Relugolix) by Giudice et al., for endometriosis-associated pain.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9512692PMC
http://dx.doi.org/10.1016/j.xcrm.2022.100748DOI Listing

Publication Analysis

Top Keywords

combination gnrh
4
gnrh antagonists
4
antagonists endometriosis
4
endometriosis balancing
4
balancing efficacy
4
efficacy side
4
side effects
4
effects endometriosis
4
endometriosis chronic
4
chronic pain
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!